17 results
424B5
IPHA
Innate Pharma
6 Feb 24
Prospectus supplement for primary offering
5:00pm
products, media or critical raw materials), (c) research and development activities related to critical technologies (including cybersecurity, artificial … , space, telecom, public health, farm products, media or critical raw materials), (c) research and development activities related to critical
20-F
cjbdtqmap9jwrwt7
24 Apr 20
Annual report (foreign)
10:43am
424B4
1vftsie adaa
18 Oct 19
Prospectus supplement with pricing info
4:08pm
F-1/A
xcxkjo048q4n
4 Oct 19
Registration statement (foreign) (amended)
4:56pm
F-1
EX-10.3
m0rujnxtoa7ogd0ux7
20 Sep 19
Registration statement (foreign)
4:08pm
F-1
EX-10.1
9o7ivgb0e8ao9 coae
20 Sep 19
Registration statement (foreign)
4:08pm
F-1
shk1 damlktn5xrf
20 Sep 19
Registration statement (foreign)
4:08pm
DRS/A
EX-10.1
4a44 9f9sz9
30 Aug 19
Draft registration statement (amended)
12:00am
DRS/A
rduyms9a91r7r
30 Aug 19
Draft registration statement (amended)
12:00am
DRS/A
EX-10.3
3wj4t6sy a5825
30 Aug 19
Draft registration statement (amended)
12:00am
DRS/A
30h8vbqpz4u2cjgo4lqq
19 Jul 19
Draft registration statement (amended)
12:00am
DRS
9qxfz6g45x6qbk
10 Jun 19
Draft registration statement
12:00am
- Prev
- 1
- Next